Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bbbb31e7315b8accd6544acf506c2d88 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D461-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D229-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-475 |
filingDate |
1984-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1985-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63f00dc767b646d0a85b2e0b33a58bb0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc5a1db54c67f8e292d3af1eeaaa2033 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a0b662559b95fc8befd47e89d758cf6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a20edf95338390dac807a09ae200e6f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_521a480406d163cfbaf1d9152593d291 |
publicationDate |
1985-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-4552877-A |
titleOfInvention |
Nb -Quaternary derivatives of sandwicine and isosandwicine methods and intermediate products in the manufacture of their derivatives and methods of using same and pharmaceutical compositions thereof |
abstract |
New Nb-quaternary 10-bromosandwicine and 10-bromoisosandwicine derivatives are disclosed which exhibit antiarrhythmic properties and adrenolytic properties and which have the formula I <IMAGE> I wherein R represents a carbon-attached organic group containing 1 to 10 carbon atoms and A(-) represents an acid anion, as well as pharmaceutical formulations thereof and processes and intermediates for their preparation. |
priorityDate |
1979-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |